Zenas BioPharma, Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | – | -90.0% | +100.0% | |
| – | -99.8% | +123,031.9% | -100.0% | |
| – | – | -368.3% | – | |
| – | -4.2% | +131.8% | +20.8% | |
| – | +33.6% | +68.6% | +84.8% | |
| – | +500.6% | -65.9% | +644.2% | |
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | – | |
| – | – | +42.5% | -118.4% | |
| – | – | – | – | |
| – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.